In a significant advancement for Parkinson’s Disease (PD) therapy, researchers have developed a targeted nano formulation ...

Scientists from the Institute of Nano Science and Technology (INST) Mohali, an autonomous institute of the Department of ...

The US company has said it is launching the Phase III trials in the first half of this year after Phase I talks with the US ...

Studies in primate models and patients with Parkinson's disease have shown that continuous ... In each of these studies, patients randomized to start therapy with a dopamine agonist had reduced ...

Researchers have developed a targeted nano formulation that can help sustained release of a hormone called 17β-Estradiol which is crucial for managing Parkinson’s Disease (PD).Many neurodegenerative a ...

New research reveals a significant reduction in Parkinson’s disease risk among autoimmune patients treated with anti-TNF or ...

Parkinson’s disease is a progressive neurodegenerative disorder that affects millions of people worldwide. In the United ...

Berlin, Germany, and Research Triangle Park, N.C., USA, Jan. 14, 2025 (GLOBE NEWSWIRE) -- Not intended for UK MediaEnrollment ongoing in the ...

Dance is therapy — whether it is to cure a medical condition or heal the soul, it has been known to help. Dancer Hrishikesh ...

To realize the promise of cell therapy for neurodegenerative disorders, S.Biomedics Co. Ltd. is looking to expand clinical ...

Many degenerative diseases, like Parkinson’s disease, multiple sclerosis, or heart failure, have always been concerning when it comes to ...

AskBio begins patient randomizing in phase II gene therapy trial for Parkinson’s disease: Berlin, Germany Wednesday, January 15, 2025, 14:00 Hrs [IST] AskBio Inc. (AskBio), a ge ...